Investing.com - InflaRx (NASDAQ:IFRX) reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that was in line with expectations.
InflaRx announced earnings per share of €-0.180 on revenue of €0.00. Analysts polled by Investing.com anticipated EPS of €-0.325 on revenue of €0.00.
InflaRx shares are down 28.9% from the beginning of the year, still down 53.22% from its 52 week high of €5.69 set on November 15, 2021.
InflaRx shares lost 2.56% in intra-day trade following the report.
InflaRx follows other major Healthcare sector earnings this month
InflaRx's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of €5.79 on revenue of €80.89B, compared to forecasts EPS of €5.43 on revenue of €80.52B.
J&J had beat expectations on October 18 with third quarter EPS of €2.55 on revenue of €23.79B, compared to forecast for EPS of €2.52 on revenue of €23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar